Title List مقالات لاتين Petrology of the hypabyssal kimberlite of the Kroonstad group II kimberlite (orangeite) cluster, South Africa: Evolution of the magma within the cluster Pharmacokinetic Studies on Metoprolol - Eudragit Matrix Tablets and Bioequivalence Consideration with Mepressor®

بر اساس عنوان

1

Petrology of the hypabyssal kimberlite of the Kroonstad group II kimberlite (orangeite) cluster, South Africa: Evolution of the magma within the cluster

2

PETROLOGY OF THE INJANA FORMATION (UPPER MIOCENE)AT ZAWITA, AMADIYA AND ZAKHO AREA, NORTHERN IRAQ

3

Petrology of the Luingo caldera (SE margin of the Puna plateau): A middle Miocene window of the arc–back arc configuration

4

Petrology of the Mesoarchean Rio Maria suite and the discrimination of sanukitoid series

5

Petrology of the Miocene igneous rocks in the Altar region, main Cordillera of San Juan, Argentina. A geodynamic model within the context of the Andean flat-slab segment and metallogenesis

6

Petrology of the Mio-Pliocene volcanism to the North and East of Ngaoundéré (Adamawa, Cameroon)

7

Petrology of the most recent ultrapotassic magmas from the Roman Province (Central Italy)

8

Petrology of the Namib Sand Sea: Long-distance transport and compositional variability in the wind-displaced Orange Delta

9

Petrology of the Nohi Rhyolite and its related granitoids: A Late Cretaceous large silicic igneous field in central Japan

10

Petrology of the Precambrian Mafic Rocks of Katekalyan Area, Bastar District, Madhya Pradesh, India

11

Petrology of the Rabaul Caldera area, Papua New Guinea

12

Petrology of the Renard igneous bodies: host rocks for diamond in the northern Otish Mountains region, Quebec

13

Petrology of titanian clinohumite and olivine at the high-pressure breakdown of antigorite serpentinite to chlorite harzburgite (Almirez Massif, S. Spain)

14

Petrology of two continental alkaline intraplate series at Emi Koussi volcano, Tibesti, Chad

15

Petrology of two diamondiferous eclogite xenoliths from the Lahtojoki kimberlite pipe, eastern Finland

16

Petrology of ultrahigh-pressure eclogites from the ZK703 drillhole in the Donghai, eastern China

17

Petrology of ultramafic lamprophyres from the Beaver Lake area of Eastern Antarctica and their relation to the breakup of Gondwanaland

18

Petrology of ultramafic xenoliths in Cenozoic alkaline rocks of northern Madagascar (Nosy Be Archipelago)

19

Petrology of volcanic products younger than 42 ka on the Lipari–Vulcano complex (Aeolian Islands, Italy): an example of volcanism controlled by tectonics

20

Petrology, geochemistry and genesis of rift-related carbonatites of Ambadungar, India

21

Petrology, geochemistry and geodynamic implications of Jurassic island arc magmatism as revealed by mafic volcanic rocks in the Mesozoic low-grade sequence, eastern Rhodope, Bulgaria

22

Petrology, geochemistry and geodynamic setting of Proterozoic igneous suites of the Orَs fold belt (Borborema Province, Northeast Brazil)

23

Petrology, geochemistry and isotopic ages of eclogites from the Dulan UHPM Terrane, the North Qaidam, NW China

24

Petrology, geochemistry and paleomagnetism of the earliest magmatic rocks of Deccan Volcanic Province, Kutch, Northwest India

25

Petrology, geochemistry and ReOs isotopes of peridotite xenoliths from Maguan, Yunnan Province: Implications for the Cenozoic mantle replacement in southwestern China

26

Petrology, geochemistry and Re–Os isotopes of peridotite xenoliths from Yantai, Shandong Province: Evidence for Phanerozoic lithospheric mantle beneath eastern North China Craton

27

Petrology, geochemistry and Sr–Nd isotopes of the Trindade and Martin Vaz volcanic rocks (Southern Atlantic Ocean)

28

Petrology, geochemistry and Sr–Nd–Pb isotopes of the volcanic rocks from Pico Island—Azores (Portugal)

29

Petrology, geochemistry and tectonic setting intrusive massives of Baft ophiolitic – melange, Southeast of Kerman, Iran

30

Petrology, geochemistry and tectonic significance of Palaeoproterozoic alkaline lamprophyres from the Jungel Valley, Mahakoshal supracrustal belt, Central India

31

PETROLOGY, GEOCHEMISTRY AND TECTONICAL ENVIRONMENT OF THE SHALAIR METAMORPHIC ROCK GROUP AND KATAR RASH VOLCANIC GROUP, SHALAIR VALLY AREA, NORTHEASTERN IRAQ

32

Petrology, Geochemistry and Tectonomagmatic Evolution of Hezar Igneous Complex (Rayen- South of Kerman- Iran): the First Description of an Arc Remnant of the Neotethyan Subduction Zone

33

Petrology, geochemistry and U–Pb geochronology of the Betic Ophiolites: Inferences for Pangaea break-up and birth of the westernmost Tethys Ocean

34

Petrology, geochemistry and zircon U–Pb and Lu–Hf isotopes of the Cretaceous dykes in the central North China Craton: Implications for magma genesis and gold metallogeny

35

Petrology, geochemistry, and geochronology of Paleoproterozoic volcanic and granitic rocks (1.89–1.88 Ga) of the Pitinga Province, Amazonian Craton, Brazil

36

Petrology, geochemistry, and geochronology of the post-collisional Triassic mangerite and syenite in the Gwangcheon area, Hongseong Belt, South Korea

37

Petrology, geochemistry, and geochronology of trondhjemites from the Qori Complex, Neyriz, Iran

38

Petrology, geochemistry, and Na metasomatism of Triassic-Jurassic non-marine clastic sediments in the Newark, Hartford, and Deerfield rift basins, northeastern USA

39

Petrology, geochemistry, and petrogenesis of mafic dykes from the Kermanshah Ophiolite in Sahneh-Harsin area of Western Iran

40

Petrology, Geochemistry, Petrogenesis and Reactivation of Volcanic Tuffs at Dair El-Kahif Area, NE-Jordan

41

Petrology, geochemistry, S, Cl and F abundances, and S oxidation state of sideromelane glass shards from Pleistocene ash layers north and south of Gran Canaria (ODP Leg 157)

42

Petrology, geochronology and Sr–Nd isotopic geochemistry of the Konso pluton, south-western Ethiopia: implications for transition from convergence to extension in the Mozambique Belt

43

Petrology, isotope geochemistry and chemical budgets of oceanic gabbros-seawater interactions in the Equatorial Atlantic

44

Petrology, major and trace element geochemistry, geochronology, and isotopic composition of granitic intrusions from the vicinity of the Bosumtwi impact crater, Ghana

45

Petrology, mineral and isotope geochemistry of the Sondalo gabbroic complex (Central Alps, Northern Italy): implications for the origin of post-Variscan magmatism

46

Petrology, mineral chemistry and Sr–Nd–Pb isotopic compositions of granitoids in the central Menderes metamorphic core complex: Constraints on the evolution of Aegean lithosphere slab

47

Petrology, mineral chemistry, and exploration significance of Fe-sulfides from the metal dispersion halo surrounding the Cadjebut Znsingle bondPb MVT deposit, Western Australia

48

Petrology, Mineralogy and Diagenesis of the Rus and Jil Formations (l- Eocene) in Najif and Samawa areas, Southern Iraq

49

Petrology, mineralogy and geochemistry of oxide minerals in polymict xenoliths from the Bultfontein kimberlites, South Africa: implication for low bulk-rock oxygen isotopic ratios

50

Petrology, Origin and Metamorphic History of Proterozoic-aged Granulites of the Natal Metamorphic Province, Southeastern Africa

51

Petrology, structural setting, timing, and geochemistry of Cretaceous volcanic rocks in eastern Mongolia: Constraints on their tectonic origin

52

Petrology, structure and tectonic significance of the Tuclame banded schists in the Sierras Pampeanas of Cَrdoba and its relationship with the metamorphic basement of northwestern Argentina

53

Petrol—something nasty in the woodshed? A review of gasoline-related burns in a British burns unit

54

Petromagnetic characteristics of Cameroon Line volcanic rocks

55

PETROMAP: MS-DOS software package for quantitative processing of X-ray maps of zoned minerals

56

Petro-mineralogy and geochemistry as tools of provenance analysis on archaeological pottery: Study of Inka Period ceramics from Paria, Bolivia

57

Petronella Clarke

58

Petrophysical analysis of limestone rocks by nuclear logging and 3D high-resolution X-ray computed microtomography

59

Petrophysical analysis of limestone rocks by nuclear logging and 3D high-resolution X-ray computed microtomography

60

Petrophysical analysis of regional-scale thermal properties for improved simulations of geothermal installations and basin-scale heat and fluid flow

61

Petro-physical Analysis of Well Logs for Reservoir Evaluation: A Case Study of Well 1 and 2 of the ‘Ictorian’ Field in the Niger Delta Basin

62

Petrophysical and consolidation behavior of mass transport deposits from the northern Gulf of Mexico, IODP Expedition 308

63

Petrophysical and durability tests on sandstones for the evaluation of their quality as building stones using Analytical Hierarchy Process (AHP)

64

Petrophysical and rock-mechanics effects of CO2 injection for enhanced oil recovery: Experimental study on chalk from South Arne field, North Sea

65

Petrophysical characterization of Chinese coal cores with heat treatment by nuclear magnetic resonance

66

Petrophysical characterization of coals by low-field nuclear magnetic resonance (NMR)

67

Petrophysical Charaterization of the Kwale Field Reservoir Sands (OML 60) from Wire-line Logs, Niger Delta, Nigeria

68

Petrophysical Constraints on Deformation Styles in Aztec Sandstone, Southern Nevada, USA

69

Petrophysical data for integrated flow modeling

70

Petrophysical data prediction from seismic attributes using committee fuzzy inference system

71

Petrophysical databases for ground characterisation: design concepts and considerations

72

Petrophysical Evaluation of Bangestan Group Formations in an Iranian Oil Field Document Type : Research Paper

73

Petrophysical evaluation of low-resistivity sandstone reservoirs with nuclear magnetic resonance log

74

Petrophysical Evaluation of Reservoir in A Selected Well (Z) in an Onshore Oil Field (X) in the Niger Delta Basin, Nigeria using Wireline Logs

75

Petrophysical Evaluation of Reservoir Sand Bodies in Kwe Field Onshore Eastern Niger Delta

76

Petrophysical laboratory measurements for basin and reservoir evaluation

77

Petrophysical Properties and Reservoir Modeling of Mishrif Formation at Amara Oil Field, Southeast Iraq

78

Petrophysical properties of bioclastic platform carbonates: implications for porosity controls during burial

79

Petrophysical properties of porous medium from Petrographic Image Analysis data

80

Petrophysical Properties of the Kahasib Formation in Missan Region, South Iraq

81

Petros D. Karkos, Spiros P. Potamianos, Maria T. Apostolidis, Giorgios Kekes

82

Petrosal approach: The avenue to the cerebellopontine angle and petrous apex

83

Petrosamine, a potent anticholinesterase pyridoacridine alkaloid from a Thai marine sponge Petrosia n. sp Original Research Article

84

Petrosectomies for invasive tumours: surgery and reconstruction

85

Petrosia testudinaria as a biomarker for metal contamination at Gulf of Mannar, southeast coast of India

86

Petrosiols A–E, neurotrophic diyne tetraols isolated from the Okinawan sponge Petrosia strongylata

87

Petrotectonic evolution of the high- to ultrahigh-pressure Maksyutov Complex, Karayanova area, south Ural Mountains: structural and oxygen isotope constraints

88

Petrotetrayndiol A induces cell cycle arrest and apoptosis in SK-MEL-2 human melanoma cells through cytochrome c-mediated activation of caspases

89

Petrous apicitis in a child: computed tomography and magnetic resonance imaging findings

90

Petrov–Galerkin and discontinuous-Galerkin methods for time-domain and frequency-domain electromagnetic simulations

91

Petrov-Galerkin finite element method for gas-liquid two-phase flow based on an incompressible two-fluid model

92

Petrov-Galerkin finite element method for gas-liquid two-phase flow based on an incompressible two-fluid model

93

Petrov-Galerkin finite element method for gas–liquid two-phase flow based on an incompressible two-fluid model Original Research Article

94

Petrov-Galerkin finite element method for solving the MRLW equation

95

Petrov–Galerkin methods for nonlinear systems without monotonicity Original Research Article

96

PETROV-GALERKIN METHODS FOR THE TRANSIENT ADVECTIVE-DIFFUSIVE EQUATION WITH SHARP GRADIENTS

97

Pets and protein: : placing domestic livestock on hobby-farms in England and Wales

98

PETs and their users: a critical review of the potentials and limitations of the privacy as confidentiality paradigm

99

PETs at CSCL Service: Underutilised Potentials for Privacy Enhancing Distance Education

100

Pets, Maternal Sensitization And Continent Of Ancestry Influence Fetal Ige Production

101

Petschek shocks of reconnection for anisotropic pressure Original Research Article

102

PET-SWNT nanocomposites through ultrasound assisted dissolution-evaporation

103

PET-THERAPY: A TRIAL FOR INSTITUTIONALIZED FRAIL ELDERLY PATIENTS

104

Petua dan Pantang Larang Tradisional dalam Alam Melayu Sarawak

105

Peudoexfoliation and poterior capular opacification

106

Peudoexfoliation in a rural population of outhern India: the Aravind Comprehenive Eye urvey

107

Peudoexfoliation yndrome in Autralian adult

108

Peudohypopyon after intravitreal triamcinolone acetonide injection for cytoid macular edema

109

Peudohypopyon of orange pigment overlying a table choroidal nevu

110

Peudomona aeruginoa in vitro corneal iolate enitivity to ofloxacin, ciprofloxacin, and trovafloxacin: a comparative tudy

111

Peudopapilledema in neurofibromatoi type 2

112

Peumusolide A, unprecedented NES non-antagonistic inhibitor for nuclear export of MEK

113

Peut-on évaluer le rôle de la sédimentation sur lʹeffet de serre à lʹéchelle de temps des cycles orbitaux ?

114

Peut-on respecter les contraintes de doses au niveau du tronc cérébral dans les irradiations des carcinomes nasopharyngés ?

115

Peut-on respecter les contraintes de doses au niveau du tronc cérébral dans les irradiations des carcinomes nasopharyngés ?

116

Peut-on se passer de l’imagerie multimodalités dans la délinéation du lit opératoire des métastases cérébrales ?

117

Peut-on se passer de l’imagerie multimodalités dans la délinéation du lit opératoire des métastases cérébrales ?

118

PEUTZ JEGHERS SYNDROME PRESENTING WITH ACUTE INTESTINAL OBSTRUCTION: A RARE CASE REPORT WITH REVIEW OF LITERATURES

119

PEUTZ-JEGHER SYNDROME CASE REPORT AND REVIEW OF LITERATURE

120

Peutz-Jeghers Syndrome With Diffuse Gastrointestinal Polyposis: Three Cases in a Family With Different Manifestations and No Evidence of Malignancy During 14 Years Follow Up

121

Peutz-Jeghers syndrome without mucocutaneous pigmentation: a case report

122

Peutz-Jeghers syndrome: 78-year follow-up of the original family

123

PeV cosmic rays: a window on the leptonic era?

124

PeV gamma rays from interactions of ultra high energy cosmic rays in the Milky Way

125

PeV scale Left–Right symmetry and baryon asymmetry of the Universe Original Research Article

126

Pexelizumab Reduces Death and Myocardial Infarction in Higher Risk Cardiac Surgical Patients

127

Peyer’s patch-mediated intestinal immune system modulating activity of pectic-type polysaccharide from peel of Citrus unshiu

128

Peygamberimiz Hz. Muhammed’in Müezzinleri

129

Peykan check, a simple continuous quality control method for hematology analyzers

130

Peyronie’s disease: A contemporary review of non-surgical treatment

131

Peyssonols A and B, Two Novel Inhibitors of the Reverse Transcriptases of Human Immunodeficiency Virus Types 1 and 2

132

PF. Barlett, Editor, Urban Place: Reconnecting with the Natural World, The MIT Press, Cambridge, MA (2005) ISBN 0-262-52443-0 (330pp., $24.00).

133

PF1022A — A novel anthelmintic cyclooctadepsipeptide. Modification and exchange of the N-methyl leucine residues

134

PF2401-SF, standardized fraction of Salvia miltiorrhiza and its constituents, tanshinone I, tanshinone IIA, and cryptotanshinone, protect primary cultured rat hepatocytes from bile acid-induced apoptosis by inhibiting JNK phosphorylation

135

PFA — A component in building materials produced from the german plastic packaging waste stream

136

PFA, a Novel Mollusk Agglutinin, Is Structurally Related to the Ribosome-Inactivating Protein Superfamily

137

Pfaffia mosaic virus: a new potyvirus found infecting Pfaffia glomerata in Brazil

138

Pfaffian and Hafnian identities in shuffle algebras

139

Pfaffian decomposition and a Pfaffian analogue of q-Catalan Hankel determinants

140

Pfaffian ideals of ladders Original Research Article

141

Pfaffian Identities: A Combinatorial Approach

142

Pfaffian representation of solutions to a coupled (2 + 1)-dimensional system

143

Pfaffian solution for coupled discrete nonlinear Schrödinger equation

144

Pfaffian solutions for the Manin-Radul-Mathieu SUSY KdV and SUSY sine-Gordon equations

145

Pfaffianization of a -dimensional generalized Kadomtsev–Petviashvili equation

146

Pfaffianization of the two-dimensional Toda lattice

147

Pfaffians and Determinants for SchurQ-Functions

148

Pfaffians, superpotentials and vector bundle moduli

149

Pfaffʹs method (I): The Mills-Robbins-Rumsey determinant Original Research Article

150

Pfaffʹs method (II): diverse applications

151

PFAM catalyzed enantioselective diethylzinc addition to imines

152

Pfanzagl exchanges diagnose an anomaly in expected utility decision theory Original Research Article

153

PFAPA and 12 Common MEFV Gene Mutations Our Clinical Experience

154

PFC full bridge rectifiers EMI modeling and analysis-common mode disturbance reduction

155

PFC Simulation of Brazilian Tensile Strength Test in Geomaterials’ Specimens with T-shaped Non-persistent Joints

156

PFC: A packet forwarding control scheme for vehicle handover over the ITS networks

157

P-FCM: a proximity—based fuzzy clustering

158

P-FCM: a proximity-based fuzzy clustering for user-centered web applications Original Research Article

159

PFCRT and DHFR-TS Sequences for Monitoring Drug Resistance in Adzopé Area of Côte d’Ivoire After the Withdrawal of Chloroquine and Pyrimethamine

160

Pfcrt Gene in Plasmodium falciparum Field Isolates from Muzaffargarh, Pakistan

161

pfcrt is more than the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective

162

PFEIFFER TYPE I SYNDROME: A GENETICALLY PROVEN CASE REPORT

163

p-FEM applied to finite isotropic hyperelastic bodies Original Research Article

164

p-FEM for finite deformation powder compaction Original Research Article

165

p-FEMs in biomechanics: Bones and arteries

166

PFeW11-doped polymer film modified electrodes and their electrocatalytic activity for H2O2 reduction Original Research Article

167

PFG NMR and internal magnetic field gradients in plant-based materials

168

PFG NMR observation of an extremely strong dependence of the ammonia self-diffusivity on its loading in H-ZSM-5

169

PFG NMR self-diffusion studies of fluid transport and surface-to-volume ratios in sands

170

PFG NMR self-diffusion studies of fluid transport and surface-to-volume ratios in sands

171

PFG NMR tracer exchange measurements of xenon in zeolites

172

PFGE characterisation and adhesion ability of Listeria monocytogenes isolates obtained from bovine carcasses and beef processing facilities

173

PFGE genotyping and antimicrobial susceptibility of Campylobacter in retail poultry meat in Estonia

174

PFGE genotyping and molecular characterization of Campylobacter spp. isolated from chicken meat

175

PFG-NMR approach to determining the water transport mechanism in polymer electrolyte membranes conditioned at different temperatures

176

PFG-NMR self-diffusion in casein dispersions: Effects of probe size and protein aggregate size

177

PFHC: A clustering algorithm based on data partitioning for unevenly distributed datasets

178

Pfiesteria piscicida and Pfiesteria shumwayae in coastal waters of Long Island, New York, USA

179

Pfiesteria: Harmful Algal Blooms as Indicators of Human: Ecosystem Interactions

180

P-filters and hereditary Baire function spaces

181

P-Filters and the perfect set property

182

p-Filtrations and the Steinberg Module

183

Pfisterʹssubform theorem for reduced special groups

184

Pfizer CEOʹs call to action

185

Pfizer Diflucan Partnership Program

186

Pfizer loses sildenafil case in Australia

187

PFKFB3 Promotes Liver Fibrosis by Regulating Aerobic Glycolysis of Hepatic Stellate Cells

188

PFKFB3 Regulates Oxidative Stress Homeostasis via Its S-Glutathionylation in Cancer

189

PFKFB4 as a prognostic marker in non-muscle-invasive bladder cancer

190

Pflanzenphysiologie, P. Schopfer, A. Brennicke. Springer Verlag, Berlin, Heidelberg (1999)

191

PF-MPC: Particle filter-model predictive control

192

PfMyb1, a Plasmodium falciparum Transcription Factor, is Required for Intra-erythrocytic Growth and Controls Key Genes for Cell Cycle Regulation Original Research Article

193

PFOS and PFOA in the livers of harbour porpoises (Phocoena phocoena) stranded or bycaught around the UK

194

p-Fractals and power series–I. Some 2 variable results

195

p-Fractals and power series—II.: Some applications to Hilbert–Kunz theory

196

PFS for Mars Express: A new approach to study Martian atmosphere Original Research Article

197

PFS on Mars Express: preparing the analysis of infrared spectra to be measured by the Planetary Fourier Spectrometer

198

PFS/MEX observations of the condensing CO2 south polar cap of Mars

199

PFS: an effective instrument for the study of martian environment Original Research Article

200

PFS-MEX observation of ices in the residual south polar cap of Mars

201

P-functions, Quasi-convex Functions, and Hadamard-type Inequalities1

202

PG 1613+426: A new sdB pulsator

203

PG&E files U.S. suit to halt destec-modesto-praxair deal

204

PG&E proposes its own retail customer accesss

205

PG&E, SCE sell 10,000 MW in plants above book value

206

pg4DB: A fuzzy object-relational system

207

PGA1 and PGA2 are selective ligands for the EP2 and EP4 prostaglandin receptor subtypes

208

PGAIPG, a Repeated Hexapeptide of Bovine and Human Tropoelastin, Is Chemotactic for Neutrophils and Lewis Lung Carcinoma Cells

209

PGAIPG, a Repeated Hexapeptide of Bovine and Human Tropoelastin, Is Chemotactic for Neutrophils and Lewis Lung Carcinoma Cells

210

PGAMgnam Style: A Glycolytic Switch Controls Biosynthesis

211

PGC-1α is induced by parathyroid hormone and coactivates Nurr1-mediated promoter activity in osteoblasts

212

PGC1-α mRNA expression cross talk with tumor volume growth and total antioxidant capacity in breast cancer model mice: following discontinuous aerobic exercise and vitamin D intake

213

PGD for aneuploidy screening: an expensive hoax?

214

PGE and Os isotopic analyses of single sample aliquots with NiS fire assay preconcentration

215

PGE and Os-isotopic variations in lavas from Kohala Volcano, Hawaii: Constraints on PGE behavior and melt/crust interaction

216

PGE enrichment in chromitite layers and the Merensky Reef of the western Bushveld Complex; a Re¯Os and Rb¯Sr isotope study

217

PGE enrichment in chromitite layers and the Merensky Reef of the western Bushveld Complex; a Re–Os and Rb–Sr isotope study

218

PGE geochemistry and Re–Os dating of massive sulfide ores from the Baimazhai Cu–Ni deposit, Yunnan province, China

219

PGE geochemistry of the Fengshan porphyry–skarn Cu–Mo deposit, Hubei Province, Eastern China

220

PGE mineralization in marginal sulfide ores of the Chineisky layered intrusion, Russia

221

PGE mineralization in the late Archaean iron-rich mafic-ultramafic Hanumalapur Complex, Karnataka, India

222

PGE reefs as an in situ crystallization phenomenon: the Nadezhda gabbronorite body, Lukkulaisvaara layered intrusion, Fennoscandian Shield, Russia

223

PGE Wins Contract to Serve New Palm Springs Muni

224

PGE2 induces oenocytoid cell lysis via a G protein-coupled receptor in the beet armyworm, Spodoptera exigua

225

PGE2 production is suppressed by chemically-synthesized Δ7-eicosatrienoic acid in macrophages through the competitive inhibition of COX-2

226

PGE2 targets squamous cell carcinoma cell with the activated epidermal growth factor receptor family for survival against 5-fluorouracil through NR4A2 induction

227

PGEN: an integrated model of leaf photosynthesis, transpiration, and conductance

228

PGEN: an integrated model of leaf photosynthesis, transpiration, and conductance

229

PGEs and other traffic-related elements in roadside soils from Sa˜o Paulo, Brazil

230

PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity

231

P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil

232

P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER).

233

P-glycoprotein activity in renal clear cell carcinoma

234

P-glycoprotein and sister P-glycoprotein sequences from mummichog, Fundulus heteroclitus, liver and intestine

235

P-Glycoprotein expression by human colonic tumor cells influences the growth of tumor cells in vitro

236

P-glycoprotein expression in human major and minor salivary glands

237

P-glycoprotein expression in Perna viridis after exposure to Prorocentrum lima, a dinoflagellate producing DSP toxins

238

P-glycoprotein in autoimmune diseases

239

P-GLYCOPROTEIN IN BLOOD BRAIN BARRIER

240

P-glycoprotein induction: an antidotal pathway for paraquat-induced lung toxicity

241

P-glycoprotein interfering agents potentiate ivermectin susceptibility in ivermectin sensitive and resistant isolates of Teladorsagia circumcincta and Haemonchus contortus

242

P-glycoprotein is downregulated in KG1a-primitive leukemia cells by LDL cholesterol deprivation and by HMG-CoA reductase inhibitors

243

P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway

244

P-GLYCOPROTEIN QUANTITATION IN ACUTE LEUKEMIA

245

P-glycoprotein: Its role in drug resistance

246

P-Glycoprotein-Mediated Efflux and Drug Sequestration in Lysosomes Confer Advantages of K562 Multidrug Resistance Sublines to Survive Prolonged Exposure to Cytotoxic Agents

247

P-glycoprotein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice

248

P-glycoproteins are not released into bile

249

PGM beamline with constant energy resolution mode for U49-2 undulator at BESSY-II

250

PGM beamline with constant energy resolution mode for U49-2 undulator at BESSY-II

251

PGO: A parallel computing platform for global optimization based on genetic algorithm

252

Pgp deficiency increases amyloid concetrations in the brain

253

PGP4, an ATP Binding Cassette P-Glycoprotein, Catalyzes Auxin Transport in Arabidopsis thaliana Roots

254

PGPR-induced defense responses in the tea plant against blister blight disease

255

pGPro1, a novel binary vector for monocot promoter characterization

256

PGR5 Is Involved in Cyclic Electron Flow around Photosystem I and Is Essential for Photoprotection in Arabidopsis

257

P-graph methodology for cost-effective reduction of carbon emissions involving fuel cell combined cycles

258

p-groups in the Betti-Mathieu group Original Research Article

259

p-GROUPS OF AUTOMORPHISMS OF ABELIAN p-GROUPS

260

p-Groups of Small Breadth

261

p-GROUPS WITH A SMALL NUMBER OF CHARACTER DEGREES AND THEIR NORMAL SUBGROUPS

262

PGRP-SC2 Promotes Gut Immune Homeostasis to Limit Commensal Dysbiosis and Extend Lifespan

263

PGS and the Critical Decision on Transfer of Defective Embryos

264

PGSE diffusion NMR studies on mononuclear and dinuclear cationic platinum salts of (S)-MeO-Biphep and (R)-p-tolyl-BINAP

265

PGSS-drying: Mechanisms and modeling

266

p-Guanidinoethyl calixarene and parent phenol derivatives exhibiting antibacterial activities. Synthesis and biological evaluation Original Research Article

267

pH – Specific synthesis, spectroscopic, and structural characterization of an assembly of species between Co(II) and N,N-bis(phosphonomethyl)glycine. Gaining insight into metal-ion phosphonate interactions in aqueous Co(II)–organophosphonate systems

268

pH adjustment for seasonal control of UF fouling by natural waters Original Research Article

269

pH Affects the Thermal Inactivation Parameters of R-Phycoerythrin from Porphyra yezoensis

270

pH and biogeochemical processes in the Gotland Basin of the Baltic Sea

271

pH and buffering capacity problems involved in the determination of ammonia in saline water using the indophenol blue spectrophotometric method

272

pH and buffering capacity problems involved in the determination of ammonia in saline water using the indophenol blue spectrophotometric method Original Research Article

273

pH and electro-responsive release behavior of MWCNT/PVA/PAAc composite microcapsules

274

pH- and glucose-sensitive glycopolymer nanoparticles based on phenylboronic acid for triggered release of insulin

275

pH and glutathion-responsive hydrogel for localized delivery of paclitaxel

276

pH and grain-size variation in leaching tests with bricks made of harbour sediments compared to commercial bricks

277

pH and heat-induced structural changes of bovine apo-α-lactalbumin

278

pH and hydrogen peroxide dual responsive supramolecular prodrug system for controlled release of bioactive molecules

279

pH and ionic strength effect on single fibrinogen molecule adsorption on mica studied with AFM

280

pH- and metal-dependent structural diversity from mononuclear to two-dimensional polymers based on a flexible tricarboxylate ligand

281

pH- and mol-ratio dependent formation of zinc(II) coordination polymers with iminodiacetic acid: Synthesis, spectroscopic, crystal structure and thermal studies

282

pH- and mol-ratio dependent tungsten(VI)–citrate speciation from aqueous solutions: syntheses, spectroscopic properties and crystal structures

283

pH and pCO2 microelectrode measurements and the diffusive behavior of carbon dioxide species in coastal marine sediments

284

pH and redox-responsive mixed micelles for enhanced intracellular drug release

285

pH and salt effects on chiral separations using affinity ultrafiltration Original Research Article

286

pH and salt responsive poly(N,N-dimethylaminoethyl methacrylate) cylindrical brushes and their quaternized derivatives

287

pH and salt-induced reversible aggregation of nonionic synthetic glycolipid vesicles

288

pH and solute concentration of suspension media affect the outcome of high hydrostatic pressure treatment of Listeria monocytogenes

289

pH- and sugar-sensitive layer-by-layer films and microcapsules for drug delivery

290

pH and surface tension dependence of mixed sodium deoxycholate–sodium dehydrocholate pre-micellar aggregation in aqueous solution

291

pH and temperature dependence of particle size in Pb1−xFexS nanoparticle films

292

pH and temperature dependent facile precipitation of nano-goethite particles in Fe(NO3)3–NaOH–NH3NH2HSO4–H2O medium

293

pH and temperature responsive porous membranes via an in situ bulk copolymerization approach

294

pH- and temperature-dependent release from cationic vesicles coexisting with copolymer of N-isopropylacrylamide and methacrylic acid

295

pH- and temperature-responsive amphiphilic diblock copolymers of 4-vinylpyridine and oligoethyleneglycol methacrylate synthesized by RAFT polymerization

296

pH- and temperature-responsive hydrogels from crosslinked triblock copolymers prepared via consecutive atom transfer radical polymerizations

297

pH- and temperature-responsive poly(aspartic acid)-l-poly(N-isopropylacrylamide) conetwork hydrogel

298

pH- and temperature-sensitive multiblock copolymer hydrogels composed of poly(ethylene glycol) and poly(amino urethane)

299

pH- and temperature-sensitive permeation through polyelectrolyte complex films composed of chitosan and polyalkyleneoxide–maleic acid copolymer

300

pH- and thermo-multi-responsive fluorescent micelles from block copolymers via reversible addition fragmentation chain transfer (RAFT) polymerization

301

pH- and thermo-responsive microcontainers as potential drug delivery systems: Morphological characteristic, release and cytotoxicity studies

302

pH- and thermosensitive thin lipid layer coated mesoporous magnetic nanoassemblies as a dual drug delivery system towards thermochemotherapy of cancer

303

pH- and time-dependent hemoglobin transitions: A case study for process modelling Original Research Article

304

p–H and T–S diagrams of 3He from 0.2 K to 20 K Original Research Article

305

pH changes in peralkaline late-magmatic fluids

306

pH changes of self-etching primers mixed with powdered dentine

307

pH control for enhanced reductive bioremediation of chlorinated solvent source zones Original Research Article

308

pH control of the structure, composition, and catalytic activity of sulfated zirconia

309

pH control on oxygen isotopic composition of symbiotic corals

310

pH control strategy in astaxanthin fermentation bioprocess by Xanthophyllomyces dendrorhous

311

pH control strategy of batch microbial transglutaminase production with Streptoverticillium mobaraense

312

pH control: handling nonlinearity and deadtime with fuzzy relational model-based control

313

pH controlled condensation of polysiloxane networks at the water–air interface

314

pH Controlled Dispersion of Non-oxide Ceramic Powders in Aqueous Media

315

pH Controlled Dispersion of Non-oxide Ceramic Powders in Aqueous Media

316

pH controlled emission of ruthenium(II)–tris–bipyridine complexes

317

pH controlled selective transport of proteins through charged ultrafilter membranes under coupled driving forces: An efficient process for protein separation

318

pH controlled size/shape in CTAB micelles with solubilized polar additives: A viscometry, scattering and spectral evaluation

319

pH controlled supramolecular structures of new silver(I) complexes based on 2-sulfoterephthalic acid and 4,4′-bipyridine

320

pH controls over anaerobic carbon mineralization, the efficiency of methane production, and methanogenic pathways in peatlands across an ombrotrophic–minerotrophic gradient

321

pH controls over anaerobic carbon mineralization, the efficiency of methane production, and methanogenic pathways in peatlands across an ombrotrophic–minerotrophic gradient

322

pH dependant sticking probability of gold colloid on silicon

323

pH dependence and thermodynamics of Hg(II) adsorption onto chitosan-poly(vinyl alcohol) hydrogel adsorbent

324

pH dependence of electrokinetic behavior of dolomite and magnesite in aqueous electrolyte solutions

325

pH Dependence of ferrous sorption onto two smectite clays

326

pH dependence of heme electrochemistry in cytochromes investigated by multiconformation continuum electrostatic calculations

327

pH Dependence of inhibitors targeting the occluding loop of cathepsin B

328

pH dependence of PDMS–PMAA IPN morphology and transport properties

329

pH Dependence of reactive sites of curcumin possessing antioxidant activity and free radical scavenging ability studied using the electrochemical and ESR techniques: Polyaniline used as a source of the free radical

330

pH dependence of steroid hormone—organic matter interactions at environmental concentrations Original Research Article

331

pH dependence of tailing in reversed-phase chromatography of a cationic dye: measurement of the strong adsorption site surface density

332

pH dependence of the absorption and emission behaviour of lumiflavin in aqueous solution

333

pH dependence of the composition and stability of MnIII–bicarbonate complexes and its implication for redox interaction of MnII with photosystem II

334

pH dependence of the dissociation of multimeric hemoglobin probed by high hydrostatic pressure Original Research Article

335

pH dependence of the fluorescence lifetime of enhanced yellow fluorescent protein in solution and cells

336

pH Dependence of the Folding of Intestinal Fatty Acid Binding Protein

337

pH dependence of the hydrophobicity of β-blocker amine compounds measured by counter-current chromatography

338

pH Dependence of the rate of DNA alkylation for (+)-duocarmycin SA and (+)-CCBI-TMI

339

pH Dependence of the Reaction Rate ofp-Bromophenacyl Bromide and of the Binding Constants of Ca2+and an Amide-Type Substrate Analog to Bovine Pancreatic Phospholipase A2

340

pH dependence of the reactions of arsenazo III with the lanthanides

341

pH dependency of ligand binding to cellobiohydrolase 1 (Cel7A): Affinity, selectivity and inhibition for designed propranolol analogues

342

pH dependency of serum ionised calcium Original Research Article

343

pH dependent binding of chlorin-p6 with phosphatidyl choline liposomes

344

pH Dependent binding of chlorin-p6 with phosphatidyl choline liposomes: Comparison between one and two-photon excited fluorescence

345

pH dependent conformational and structural changes of xylanase from an alkalophilic thermophilic Bacillus sp (NCIM 59)

346

pH dependent copper binding properties of a CuA azurin variant with both bridging cysteines replaced with serines

347

pH dependent dynamic behavior of flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) in femtosecond to nanosecond time scale

348

pH dependent fluorescence switching in salicylideneaniline: ‘off–on–off’ operation controlled by surfactant micelles

349

pH Dependent formations of dinuclear molybdenum(V) and incomplete cubane molybdenum(IV) complexes with nitrilotriacetate

350

pH dependent growth of poly(L-lysine)/poly(L-glutamic) acid multilayer films and their cell adhesion properties

351

pH dependent interaction of biofunctionalized CdS nanoparticles with nucleobases and nucleotides: A fluorimetric study

352

pH dependent phosphate hydrolysis by a lanthanide EF-hand peptide

353

pH Dependent photophysics and role of medium on photoinduced electron transfer between ruthenium polypyridyl complex and anthraquinone

354

pH dependent protein stability: A quantitative approach based on Kramerʹs barrier escape

355

pH dependent reversible aggregation of Chitosan and glycol-Chitosan stabilized silver nanoparticles

356

pH dependent self assembly of (beta)-amyloid(10-35) and (beta)amyloid(10-35)-PEG3000

357

pH Dependent self-assembly of dimetallic lanthanide complexes

358

pH Dependent structural diversity of lead compounds based on new flexible ligand [3-(2-pyridyl)-1-pyrazolyl] acetic acid

359

pH dependent surface enhanced Raman study of Phe + Ag complex and DFT calculations for spectral analysis

360

pH dependent uptake of porphyrin-type photosensitizers by solid tumor cells in vitro is not induced by modification of transmembrane potential

361

PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt

362

PH effect in the photocatalytic transformation of a phenyi-urea herbicide

363

pH effect on cysteine and cystine behaviour at hanging mercury drop electrode

364

pH effect on OH radical production in photo/ferrioxalate system

365

pH Effect on the binding of chlorin derivatives with Cremophor EL, a potential drug delivery vehicle

366

pH effect on the electrochemical redox reaction of disulfide with polyaniline film electrode in organic solution

367

pH Effect on the Size of Graphene Quantum dot Synthesized by Using Pulse Laser Irradiation

368

pH Effect on the spectroscopic behavior and photoinduced generation of semiquinone anion radical of hypocrellin B

369

pH effects on collagen fibrillogenesis in vitro: Electrostatic interactions and phosphate binding

370

pH effects on drug interactions with lipid bilayers by liposome electrokinetic chromatography

371

pH effects on optical and DNA binding properties of a thiophene-containing ruthenium(II) complex

372

pH effects on the adherence and fouling propensity of extracellular polymeric substances in a membrane bioreactor

373

pH effects on the binding of oxygen to non-vertebrate monomeric hemoglobins. A linked function model.

374

pH effects on the cellular uptake of four photosensitizing drugs evaluated for use in photodynamic therapy of cancer

375

pH effects on the hyaluronan hydrolysis catalysed by hyaluronidase in the presence of proteins. Part III. The electrostatic non-specific hyaluronan–hyaluronidase complex

376

pH effects on the hyaluronan hydrolysis catalysed by hyaluronidase in the presence of proteins: Part II. The electrostatic hyaluronan – Protein complexes

377

pH effects on the second-order nonlinear optical properties of surface modified CdS nanoparticles

378

pH evolution in sea ice grown at an outdoor experimental facility

379

P–H functionalised phosphinoalkoxides as ligands: synthesis and catalytic properties of [Cp2Zr(Me)(cyclo-1-O-2-PH(Tipp)-C6H10)] (Tipp=2,4,6-Pri3C6H2), [Cp2Zr(Me)(cyclo-1-O-2-PH(Tipp){Mo(CO)5}–C6H10)] and [Cp2Zr(BH4)(cyclo-1-O-2-PH(Mes)(BH3)–C6H10)] (Mes=2

380

pH gradient high-performance liquid chromatography: theory and applications

381

pH gradient reversed-phase liquid chromatography as a fractionation tool for the separation of peptides

382

pH has a role in cystic fibrosis infections

383

pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque

384

pH HOMEOSTASIS OF THE CIRCADIAN SPORULATION RHYTHM IN CLOCK MUTANTS OF NEUROSPORA CRASSA

385

pH Independent Complexation of 2-Aminobenzimidazole with β-cyclodextrin

386

pH indications in aqueous organic photodecompositions with carbonyl and hydroxyl groups

387

pH Induced Aggregation and Weak Gel Formation of Whey Protein Polymers

388

pH influence on root growth and nutrient uptake of Pinus pinaster seedlings

389

pH influence on sorption characteristics of heavy metal in the vadose zone

390

pH Influence on the stability of foams with protein–polysaccharide complexes at their interfaces

391

pH is a good predictor of the distribution of anoxygenic purple phototrophic bacteria in Arctic soils

392

pH is a good predictor of the distribution of anoxygenic purple phototrophic bacteria in Arctic soils

393

pH measurement and control in solvent extraction using column contractors

394

pH MEASUREMENT USING MICRO GAP STRUCTURE

395

pH Metric, Spectroscopic and Thermodynamic Study of Complexation Behavior of 2-aminobenzothiazole with Ni (II) in Presence of Amino Acids

396

pH microelectrode–micropipette system for the measurement of enzyme reactions in a picoliter volume of a living plant cell Original Research Article

397

pH modelling by neural networks. Application of control and validation data series in the Middle Loire river

398

pH modelling by neural networks. Application of control and validation data series in the Middle Loire river

399

pH Modulates the Quinone Position in the Photosynthetic Reaction Center from Rhodobacter sphaeroides in the Neutral and Charge Separated States

400

pH modulation of transport properties of alamethicin oligomers inserted in zwitterionic-based artificial lipid membranes Original Research Article

401

pH neutralization and influence on mechanical strength in self-adhesive resin luting agents

402

pH of activated carbon surface as an indication of its suitability for H2S removal from moist air streams Original Research Article

403

404

pH of soul: How does acid-base balance affect our cognition?

405

pH of the Martian surface

406

pH optical sensors based on sol–gels: Chemical doping versus covalent immobilization Original Research Article

407

pH Oscillations and complex reaction dynamics in the non-buffered chlorite–thiourea reaction

408

pH polymeric membrane microelectrodes based on neutral carriers and their application in aquatic environments Original Research Article

409

pH pre-corrected liquid hot water pretreatment on corn stover with high hemicellulose recovery and low inhibitors formation

410

pH programming in capillary electrophoresis by means of temperature programming

411

pH regulates key players of nitrification in paddy soils

412

pH regulates key players of nitrification in paddy soils

413

pH regulation as a method of intensification of soil electroremediation

414

pH regulation during ischaemia-reperfusion of isolated rat hearts, and metabolic effects of 2,3-butanedione monoxime

415

pH Regulation in Anoxic Plants

416

pH regulation of alkaline wastewater with carbon dioxide: A case study of treatment of brewery wastewater in UASB reactor coupled with absorber

417

pH regulation of carbon and nitrogen dynamics in two agricultural soils

418

pH regulation of carbon and nitrogen dynamics in two agricultural soils

419

pH responsive “off–on–off” luminescent switch of a novel ruthenium(II) complex [Ru(bpy)2(pipipH2)]2+

420

pH responsive cross-linked polymeric matrices based on natural polymers: effect of process variables on swelling characterization and drug delivery properties

421

pH responsive itaconic acid grafted alginate microspheres for the controlled release of nifedipine

422

pH responsive luminescent switches of ruthenium(II) complexes containing two imidazole groups: Synthesis, spectroscopy, electrochemistry and theoretical calculations

423

pH Responsive micelle self-assembled from a new amphiphilic peptide as anti-tumor drug carrier

424

pH responsiveness of two-layer nano-composite membrane with ultrathin cylindrical nanopores PS-b-P4VP film

425

pH sensing in living cells using fluorescent microspheres

426

pH sensitive halloysite-sodium hyaluronate/poly(hydroxyethyl methacrylate) nanocomposites for colon cancer drug delivery

427

pH Sensitive Hydrogel Based Acrylic Acid for Controlled Drug Release

428

pH Sensitive Hydrogel Based on Poly(Acrylic Acid) and Cellulose Nanocrystals

429

pH sensitive N-succinyl chitosan grafted polyacrylamide hydrogel for oral insulin delivery

430

pH sensitive photoconductor based on poly(para-phenylene-vinylene)

431

pH sensitive photoconductor based on poly(para-phenylene-vinylene)

432

pH Sensitive polypropylene porous membrane prepared by grafting acrylic acid in supercritical carbon dioxide

433

pH sensitive silica nanotubes as rationally designed vehicles for NSAIDs delivery

434

pH Sensitive supramolecular assembling system between a new linear water soluble β-cyclodextrin terpolymer and an amphiphilic poly(ethylene oxide)

435

pH sensitivity of polyaniline and its substituted derivatives

436

pH sensor based on a detection sol–gel layer onto optical fiber

437

pH sensor based on deposited film of lead oxide on aluminum substrate electrode

438

pH sensor based on the crown heteropolyanion K28Li5H7P8W48O184·92H2O immobilized using a layer by layer assembly process

439

pH sensors with lithium lanthanum titanate sensitive material: applications in food industry

440

pH sequential ozonation of domestic and wine-distillery wastewaters

441

pH simulation model in a mixed layer of a lacustrine environment (the case of Lake Orta)

442

pH simulation model in a mixed layer of a lacustrine environment (the case of Lake Orta)

443

pH stress can cause cell elongation in Bacillus and Clostridium species: a research note

444

pH Switched sensitisation of europium(III) by a dansyl group

445

pH switching on-off semi-IPN hydrogel based on cross-linked poly(acrylamide-co-acrylic acid) and linear polyallyamine

446

pH transients in hydroxyapatite chromatography columns—Effects of operating conditions and media properties

447

pH Transients in hydroxyapatite chromatography columns—Experimental evidence and phenomenological modeling

448

pH transitions in cation exchange chromatographic columns containing weak acid groups

449

pH Transitions in Ion-Exchange Systems: Role in the Development of a Cation-Exchange Process for a Recombinant Protein

450

pH triggered release of protective poly(ethylene glycol)-b-polycation copolymers from liposomes

451

pH tunable morphology of the gold nanoparticles produced by citrate reduction

452

pH value and ionic strength effects on the adsorption kinetics of protein/phospholipid at the chloroform/water interface

453

pH Value controlled structures: from macrocyclic complex monomer to 2D macrocyclic sheet

454

pH value dependence of the photothermal and optical absorption spectra for polyaniline films

455

pH variability and CO2 induced acidification in the North Sea

456

pH, alkalinity and total CO2 in coastal seawater by potentiometric titration with a difference derivative readout Original Research Article

457

pH, Dissolved Oxygen, and Adsorption Effects on Metal Removal in Anaerobic Bioreactors

458

pH, Photo, and Aeration Period Effects on Arthrospira maxima Growth: Taguchi Technique

459

pH, serum proteins and ionic strength influence the uptake of merocyanine 540 by WiDr cells and its interaction with membrane structures

460

Ph.D. in Business Management at Istanbul University: A New Programme in English Ready to Commence in Fall 2016

461

Ph.D. in Nursing from Theory to Reality

462

Ph.D. Students of Irving Segal

463

pH/redox responsive core cross-linked nanoparticles from thiolated carboxymethyl chitosan for in vitro release study of methotrexate

464

pH/Temperature control of interpolymer complexation between poly(acrylic acid) and weak polybases in aqueous solutions

465

pH/temperature sensitive poly(ethylene glycol)-based biodegradable polyester block copolymer hydrogels

466

pH/temperature-responsive behaviors of semi-IPN and comb-type graft hydrogels composed of alginate and poly(N-isopropylacrylamide)

467

pH/temperature-sensitive 4-arm poly(ethylene glycol)-poly(amino urethane) copolymer hydrogels

468

Ph[PhC(O)NH]2PyNC(O)Ph: a new mesomeric stabilized azaylide. Synthesis, crystal structure and IR spectroscopic results

469

Ph[PhC(O)NH]2PyNC(O)Ph: a new mesomeric stabilized azaylide. Synthesis, crystal structure and IR spectroscopic results

470

Ph3BiCO3: a mild reagent for in situ oxidation of urazoles to triazolinediones

471

Ph3P/Br2/n-Bu4NNO2 as an efficient system for the preparation of N-nitrosamines and azides

472

PHA based denitrification: Municipal wastewater vs. acetate

473

PHA immune response assay in captive zebra finches is modulated by activity prior to testing

474

PHA production by mixed cultures: A way to valorize wastes from pulp industry

475

PHA production from wastewater by mixed microbial culture under short-term microbial enrichment

476

PHA stimulation may be useful for FDXR gene expression-based biodosimetry

477

PHA/IL2: An Efficient Mitogen Cocktail for Cytogenetic Studies of Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

478

PHA: A fast potential-based hierarchical agglomerative clustering method

479

PHAC SYNTHASES AND PHA DEPOLYMERASES: THE ENZYMES THAT PRODUCE AND DEGRADE PLASTIC

480

PHACE(S) syndrome: Report of a case with new ocular and systemic manifestations

481

PHACES (Photographs of Academic Clinicians and Their Educational Status): A Tool to Improve Delivery of Family-Centered Care

482

PHACES syndrome with cataract and Horner’s syndrome: a case report

483

Phaco chop: Matering technique, optimizing technology, and avoiding complication

484

Phacodynamic: An Apiration Flow v Vacuum Comparion

485

Phacodynamic: Matering the Tool and Technique of Phacoemulification urgery; Fourth Edition

486

Phacoemulification and len implantation after cleral buckling urgery

487

Phacoemulification Aociated Corneal Damage Evaluated by Corneal Volume

488

Phacoemulification cataract extraction and poterior chamber len implantation in patient with uveiti

489

Phacoemulification of Cataract in Patient Receiving Coumadin Therapy: Ocular and Hematologic Rik Aement Original Reearch Article

490

Phacoemulification v mall-Inciion Manual Cataract urgery: An Expert Trial

491

Phacoemulsification of bilateral cataracts in two pet rabbits

492

Phacomorphic Glaucoma as the First Manifestation of the Choroidal Malignant Melanoma

493

Phacotrabeculectomy and Implantation of Intraocular Lenses with Releasable Sutures and Antimetabolite Agents: Efficacy and Safety

494

Phacotrabeculectomy With Mitomycin C in Patient With Uveiti

495

Phae I/II randomized trial of intrahepatic arterial infuion chemotherapy with ciplatin and chemoembolization with ciplatin and polyvinyl ponge in patient with ocular melanoma metatatic to the liver

496

Phaehyphomycosis caused by Veronea bothryosa

497

Phaeoacremonium tuscanicum, a new fungal pathogen associated with oak decline in Zagros forests, Iran

498

Phaeochromocytoma

499

Phaeochromocytoma—views on current management

500

Phaeocystis blooms in the global ocean and their controlling mechanisms: a review

501

Phaeohyphomycosis caused by Diaporthe phaseolorum in an immunocompetent patient in Thailand: a case report

502

Phaeomoniella chlamydospora: causal agent of vine decline (Vitis vinifera) in the vineyards of Slovakia

503

Phaeophytins from Gossypium mustelinum Miers ex Watt (Malvaceae)

504

Phage adsorption to Lactobacillus plantarum: Influence of physiological and environmental factors

505

Phage coated magnetoelastic micro-biosensors for real-time detection of Bacillus anthracis spores

506

Phage Display and Crystallographic Analysis Reveals Potential Substrate/Binding Site Interactions in the Protein Secretion Chaperone CsaA from Agrobacterium tumefaciens

507

Phage display as a tool for the directed evolution of enzymes

508

Phage display combinatorial libraries of short peptides: ligand selection for protein purification

509

Phage display identifies an Eastern equine encephalitis virus glycoprotein E2-specific B cell epitope

510

Phage display identifies an Eastern equine encephalitis virus glycoprotein E2-specific B cell epitope

511

Phage display of functional, full-length human and viral membrane proteins

512

Phage Display Reveals Multiple Contact Sites between FhuA, an Outer Membrane Receptor of Escherichia coli, and TonB

513

Phage Display Screening Reveals an Association Between Germline-specific Transcription Factor Oct-4 and Multiple Cellular Proteins

514

Phage display selection and characterization of single-chain recombinant antibodies against Eimeria tenella sporozoites

515

Phage display selection and characterization of single-chain recombinant antibodies against Eimeria tenella sporozoites

516

Phage display techniques to obtain antibodies against turbot (Scophthalmus maximus) blood cells

517

Phage display technology for stem cell delivery and systemic therapy

518

Phage display technology: clinical applications and recent innovations

519

Phage FR38 Treatment on Sprague Dawley Rat Inferred from Blood Parameters and Organ Systems

520

Phage Genomics: Small Is Beautiful

521

Phage inactivation of foodborne pathogens on cooked and raw meat

522

Phage inactivation of Staphylococcus aureus in fresh and hard-type cheeses

523

Phage Integrases: Biology and Applications Review Article

524

Phage Langmuir monolayers and Langmuir–Blodgett films

525

Phage Like It HOT: Solution Structure of the Bacteriophage P1-Encoded HOT Protein, a Homolog of the θ Subunit of E. coli DNA Polymerase III

526

Phage ø29 DNA polymerase residues involved in the proper stabilisation of the primer-terminus at the 3′-5′ exonuclease active site

527

Phage P22 Procapsids Equilibrate with Free Coat Protein Subunits

528

Phage Peptide Libraries As a Source of Targeted Ligands

529

Phage selection for site-specific incorporation of unnatural amino acids into proteins in vivo Original Research Article

530

Phage Therapy in COVID-19 Treatment

531

Phage therapy: A modern tool to control bacterial infections

532

Phage therapy: assessment of the efficacy of a bacteriophage isolated in the treatment of salmonellosis induced by Salmonella enteritidis in mice

533

Phage therapy—advantages over antibiotics?

534

Phage Types of multidrug resistant Salmonella species in a rural area of Maharashtra, India

535

Phage types, virulence genes and PFGE profiles of Shiga toxin-producing Escherichia coli O157:H7 isolated from raw beef, soft cheese and vegetables in Lima (Peru)

536

Phage typing combined with pulsed-field gel electrophoresis and random amplified polymorphic DNA increases discrimination in the epidemiological analysis of Salmonella enteritidis strains

537

Phage typing, PCR amplification for mecA gene, and antibiotic resistance patterns as epidemiologic markers in nosocomial outbreaks of methicillin resistant Staphylococcus aureus

538

Phage versus Phagemid Libraries for Generation of Human Monoclonal Antibodies

539

Phage λ takes the first exit

540

Phage-based nanomaterials for biomedical applications

541

Phage-borne peptidomimetics as immunochemical reagent in dot-immunoassay for mycotoxin zearalenone

542

Phage-displayed Antibody Libraries of Synthetic Heavy Chain Complementarity Determining Regions

543

Phage-displayed peptide library screening for preferred human substrate peptide sequences for transglutaminase 7

544

Phage-displayed peptides that mimic zearalenone and its application in immunoassay

545

Phage-displayed protein chip based on SPR sensing

546

Phagemid Vectors for Phage Display: Properties, Characteristics and Construction Review Article

547

Phage-peptide Display Identifies the Interferon-responsive, Death-activated Protein Kinase Family as a Novel Modifier of MDM2 and p21WAF1

548

Phage-related DNA polymorphism in dairy and probiotic Lactobacillus

549

Phage-resistance linked to cell heterogeneity in the commercial strain Lactobacillus delbrueckii subsp. lactis Ab1

550

Phage-resistant mutants of Lactobacillus delbrueckii may have functional properties that differ from those of parent strains

551

Phagocyte functions in stressed rats: comparison of modulation by glutamine, arginine and ornithine 2-oxoglutarate

552

Phagocyte implications in advanced atherosclerosis

553

Phagocyte-derived S100 proteins in autoinflammation: Putative role in pathogenesis and usefulness as biomarkers

554

Phagocyte-Generated Superoxide Reduces Fe3+ to Displace It from the Surface of Asbestos

555

Phagocyte-induced lipid peroxidation of different intravenous fat emulsions and counteractive effect of vitamin E

556

Phagocyte–myocyte interactions and consequences during hypoxic wound healing

557

Phagocytes and oxidative stress

558

Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules

559

Phagocytic Activity and IL-1 Alpha Levels for Asthma Patients

560

Phagocytic activity of alveolar macrophages toward polystyrene latex microspheres and PLGA microspheres loaded with anti-tuberculosis agent

561

Phagocytic Activity of Patients with a Diabetic Foot in Wasit Province, Iraq

562

Phagocytic activity of scallop (Pecten maximus) haemocytes maintained in vitro

563

Phagocytic activity of turbot (Scophthalmus maximus) leucocytes: opsonic effect of antibody and complement

564

Phagocytic activity of two lines of chickens divergently selected for antibody production

565

Phagocytic activity of two lines of chickens divergently selected for antibody production

566

Phagocytic and chemotactic responses of manila and carpet shell clam haemocytes against Vibrio tapetis, the causative agent of brown ring disease

567

Phagocytic and Metabolic Activities of Macrophages from Mummichog Naturally Exposed to Pulp Mill Effluents in the Miramichi River

568

Phagocytic capacity and apoptosis of peripheral blood cells from patients with iron deficiency anemia

569

Phagocytic cells of the thymic reticulum interact with thymocytes via extracellular matrix ligands and receptors

570

Phagocytic function and metabolite production in thioacetamide-induced liver cirrhosis: a comparative study in perfused livers and cultured Kupffer cells

571

Phagocytic killing of microorganisms by radical processes:consequences of the reaction of hydroxyl radicals with chloride yielding chlorine atoms

572

Phagocytic response of macrophages from the pronephros of American plaice (Hipoglossoides platessoides) exposed to contaminated sediments from Baie des Anglais, Quebec

573

Phagocytic Response of Terrestrial and Aquatic Invertebrates Following in Vitro Exposure to Trace Elements

574

Phagocytosis and development: back to the future

575

Phagocytosis and innate immunity

576

Phagocytosis and respiratory burst activity of haemocytes from the ivory snail, Babylonia areolata

577

Phagocytosis by B-cells and neutrophils in Atlantic salmon (Salmo salar L.) and Atlantic cod (Gadus morhua L.)

578

Phagocytosis in pup and adult harbour, grey and harp seals

579

Phagocytosis in pup and adult harbour, grey and harp seals

580

Phagocytosis inhibition of clam and mussel haemocytes by Perkinsus atlanticus secretion products.

581

Phagocytosis of Candida albicans by concanavalin-A activated peritoneal macrophages

582

Phagocytosis of Candida albicans by concanavalin-A activated peritoneal macrophages

583

Phagocytosis of candida albicans by lymphatic tumour cells in vitro

584

Phagocytosis of Candida albicans by metastatic and non metastatic human breast cancer cell lines in vitro

585

Phagocytosis of chemically modified carbon materials

586

Phagocytosis of Loma salmonae (Microsporidia) spores in Atlantic salmon (Salmo salar), a resistant host, and chinook salmon (Oncorhynchus tshawytscha), a susceptible host

587

Phagocytosis of N-acetyl-d-glucosamine particles, a Th1 adjuvant, by RAW 264.7 cells results in MAPK activation and TNF-α, but not IL-10, production

588

Phagocytosis of wear debris by osteoblasts affects differentiation and local factor production in a manner dependent on particle composition

589

Phagocytosis, endosomal/lysosomal system and other cellularaspects of macrophage activation by Canova medication

590

Phagocytotic removal of apoptotic endocrine cells by folliculostellate cells and its functional implications in clusterin accumulation in pituitary colloids in helmeted guinea fowl (Numida meleagris)

591

Phagostimulatory effect of uptake of PLGA microspheres loaded with rifampicin on alveolar macrophages

592

Phagotrophic algae in a wastewater stabilization pond

593

PHAHs in 14 principal river sediments from Hai River basin, China Original Research Article

594

Phakic Intraocular Lenses and their Special Indications

595

Phakic IOL: A photo finih?

596

Phakic poterior chamber intraocular len for the correction of aniometropia and treatment of amblyopia

597

Phakomatosis pigmentovascularis type IIa

598

Phalangeal osteochondroma: a cause of childhood trigger finger

599

Phalangeal osteosonogrammetry age-related changes and assessment of a Lebanese reference population

600

Phalangeal Tuberculosis After Mallet Finger Treatment: A Case Report

601

Phalangeal ultrasonography in forearm fracture discrimination

602

Phalanx-like osseous structure posterior to the cervical vertebrae: a hitherto unreported location for a rare anomaly

603

Phalaropes feeding at a coastal front in Santa Monica Bay, California

604

PHALEN TEST POSITIVATION TIME an‎d ITS CORRELATION WITH ELECTRONEUROMYOGRAPHY

605

Phallometric testing with sexual offenders: Limits to its value

606

Phalloplasty for an amputated phallus in intersex patients

607

Phalloplasty in female-to-male transsexuals using free radial osteocutaneous flap: a series of 22 cases, ,

608

Phanerochaete chrysosporium pretreatment of biomass to enhance solvent production in subsequent bacterial solid-substrate cultivation

609

Phanerochaete flavido-alba ligninolytic activities and decolorization of partially bio-depurated paper mill wastes

610

Phanerozoic atmospheric CO2 change: evaluating geochemical and paleobiological approaches

611

Phanerozoic biodiversity: rocks or real?

612

Phanerozoic burial and unroofing history of the western Slave craton and Wopmay orogen from apatite (U–Th)/He thermochronometry

613

Phanerozoic changes in the high-rank suprageneric diversity structure of brachiopods: Linear and non-linear effects

614

Phanerozoic continental growth and gold metallogeny of Asia

615

Phanerozoic Continental Growth of East and Southeast Asia: Timings of Amalgamation and Accretion

616

Phanerozoic Geodynamic Evolution of the Circum-Italian Realm

617

Phanerozoic high-pressure eclogite and intermediate-pressure granulite facies metamorphism in the Gyeonggi Massif, South Korea: Implications for the eastward extension of the Dabie–Sulu continental collision zone

618

Phanerozoic hot spot traces and paleogeographic reconstructions of the Siberian continent based on interaction with the African large low shear velocity province

619

Phanerozoic Large Igneous Provinces (LIPs), HEATT (Haline Euxinic Acidic Thermal Transgression) episodes, and mass extinctions

620

Phanerozoic marine biodiversity follows a hyperbolic trend

621

Phanerozoic organic-carbon-rich marine sediments: Overview and future research challenges

622

Phanerozoic paleogeography, paleoenvironment and lithofacies maps of the circum-Atlantic margins

623

Phanerozoic polar wander, palaeogeography and dynamics

624

Phanerozoic reactivation along a fundamental Proterozoic crustal fault, the Darling River Lineament, Australia: constraints from apatite fission track thermochronology

625

Phanerozoic reactivation of the Archean North China Craton through episodic magmatism: Evidence from zircon U–Pb geochronology and Hf isotopes from the Liaodong Peninsula

626

Phanerozoic Reconstitution of Indian Shield as Aftermath of Gondwana Break-up

627

Phanerozoic tectonics of the South China Block: Key observations and controversies

628

Phanerozoic tectonothermal events of the Xuefengshan Belt, central South China: Implications from UPb age and LuHf determinations of granites

629

Phanerozoic, pre-Cretaceous thermotectonic events in southern Sweden revealed by fission track thermochronology

630

Phanerozoic, pre-Cretaceous thermotectonic events in southern Sweden revealed by fission track thermochronology

631

Phanquinone: a useful fluorescent pre-chromatographic derivatization reagent for liquid chromatographic analyses of amino acid dosage forms Original Research Article

632

PHANTASTICA Regulates Development of the Adaxial Mesophyll in Nicotiana Leaves

633

Phantom accretion by black holes and the generalized second law of thermodynamics

634

Phantom and in vivo study of the look–locher T1 mapping method

635

Phantom Archean crust in Mangaia hotspot lavas and the meaning of heterogeneous mantle

636

Phantom bursting is highly sensitive to noise and unlikely to account for slow bursting in -cells: Considerations in favor of metabolically driven oscillations

637

Phantom dosimeters examined by NMR analysis: a promising technique for 3-D determination of absorbed dose

638

Phantom elasticity reconstruction with Digital Image Elasto-Tomography

639

Phantom endometriosis of the sciatic nerve

640

Phantom evolution in power-law potentials Original Research Article

641

Phantom faces for face analysis

642

Phantom feelings in the thalamus explained

643

Phantom Friedmann cosmologies and higher-order characteristics of expansion

644

Phantom limb after stroke: An underreported phenomenon

645

Phantom limb pain

646

Phantom limb pain

647

Phantom limb pain in pediatric burn survivors

648

Phantom Limb Sensation (PLS) and Phantom Limb Pain (PLP) among Young Landmine Amputees

649

PHANTOM LIMB SYNDROME: A REVIEW

650

Phantom limbs – Or phantoms of phantom limbs?

651

Phantom maps and homology theories

652

Phantom Maps and Purity in Modular Representation Theory, III

653

Phantom maps and the Gray index

654

Phantom Maps in the Stable Module Category

655

Phantom materials for single point imaging pulse sequences

656

Phantom nurses at real bedsides

657

658

Phantom reflexes: Muscle contractions at a frequency not physically present in the input stimuli

659

Phantom study of radiotracer concentration quantification in breast scintigraphy

660

Phantom thermodynamics Original Research Article

661

Phantom tumor of the lung in heart failure patient

662

Phantom Validation of Tc-99m Absolute Quantification in a SPECT/CT Commercial Device

663

PHANTOM: A Monte Carlo event generator for six parton final states at high energy colliders Original Research Article

664

Phantom: a simple and effective flow control scheme

665

Phantom-based performance evaluation: Application to brain segmentation from magnetic resonance images

666

Phantom-like behaviour in dilatonic brane-world scenario with induced gravity Original Research Article

667

Phantom-limb lengthening after heart transplant

668

Phantom-limb pain: characteristics, causes, and treatment

669

Phantom-node method for shell models with arbitrary cracks

670

Phantoms and spectres: capital and labour at the millennium

671

Phantoms of regularity in the sea of quantum chaos

672

PhAP protease from Pseudoalteromonas haloplanktis TAC125: Gene cloning, recombinant production in E. coli and enzyme characterization

673

Phar Lap and duodenitis-proximal jejunitis

674

Pharaoh and the Divine Wont of Respiting: A Critical Analysis of Quranic Themes

675

PHARAOH EAGLE-OWL BUBO ASCALAPHUS (SAVIGNY, 1809) (STRIGIFORMES, STRIGIDAE), THE “SHROUDED IN MYSTERY” OWL OF IRAQ an‎d IRAN

676

Pharmaceutical Advances and Proteomics Researches

677

Pharmaceutical advertising versus research spending: are profits more important than patients?

678

Pharmaceutical analysis of 5-aminolevulinic acid in solution and in tissues

679

Pharmaceutical Analysis, D.C. Lee, M. Webb (Eds.). Blackwell Publishing Ltd, Oxford, UK (2003)

680

Pharmaceutical and Bio-analytical Applications of Ion Mobility Spectrometry for Determination of Clopidogrel (Plavix)

681

Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy

682

Pharmaceutical and clinical aspects of p-phenylene-diamine patch test material

683

PHARMACEUTICAL AND CLINICAL EVALUATION OF INTRAVENOUS ADMIXTURE OF DOBUTAMINE AND DOPAMINE USED IN TREATMENT HYPOTENSION IN NEONATAL INTENSIVE CARE UNITS

684

Pharmaceutical and industrial protein engineering: Where we are?

685

Pharmaceutical and nutraceutical effects of Pinus pinaster bark extract

686

Pharmaceutical and nutraceutical management of canine osteoarthritis: Present and future perspectives

687

Pharmaceutical and personal care products (PPCPs) in urban receiving waters l

688

Pharmaceutical and personal care products in tile drainage following surface spreading and injection of dewatered municipal biosolids to an agricultural field Original Research Article

689

Pharmaceutical and Related Drugs

690

Pharmaceutical applications of a flurbiprofen sensor

691

Pharmaceutical applications of calorimetric measurements in the new millennium

692

Pharmaceutical applications of confocal laser scanning microscopy: The physical characterisation of pharmaceutical systems

693

Pharmaceutical applications of dynamic mechanical thermal analysis

694

Pharmaceutical applications of embryonic stem cells

695

Pharmaceutical applications of isoelectric focusing on microchip with imaged UV detection

696

Pharmaceutical applications of magnetic resonance imaging (MRI)

697

Pharmaceutical applications of Mid-IR and Raman spectroscopy

698

Pharmaceutical applications of some spanish clays (sepiolite, palygorskite, bentonite): some preformulation studies

699

Pharmaceutical applications of various natural gums, mucilages and their modified forms

700

Pharmaceutical Approaches and Advancements in Male Contraception

701

Pharmaceutical aspects of parenteral nutrition: from now to the future

702

Pharmaceutical Care Approach to Hearing Loss

703

Pharmaceutical Care Education and Practice in Jordan in the New Millennium

704

Pharmaceutical care impact on health-related quality of life (HRQOL) and pharmaco-economical burden on COVID recovered diabetic patients with comorbid condition

705

Pharmaceutical Care Program for Patients With Uncontrolled Hypertension: Report of a Double-Blind Clinical Trial With Ambulatory Blood Pressure Monitoring

706

Pharmaceutical challenges in veterinary product development

707

Pharmaceutical Characterization and in vivo Evaluation of the Possible Anti-Inflammatory Effect of Topical Allopurinol Gel in an Animal Model

708

Pharmaceutical Characterization of Aqueous Stem Bark Extract of Bridelia ferruginea Benth (Euphorbiaceae)

709

Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment

710

Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation

711

Pharmaceutical Co-Crystallization: Regulatory Aspects, Design, Characterization, and Applications

712

Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development

713

Pharmaceutical companies and the third world

714

Pharmaceutical companies pay criminal fine for fxobal price fixing

715

Pharmaceutical companies pledge vaccines for developing countries

716

Pharmaceutical companies target plant products for drugs of the future

717

Pharmaceutical company trials and the integrity of medical research

718

Pharmaceutical Compounds as Photostabilizers

719

Pharmaceutical cost management and access to psychotropic drugs: The U.S. context

720

Pharmaceutical economy and the economic assessment of drugs in France

721

Pharmaceutical Electrochemistry: the Electrochemical Behaviour of Paracetamol at ZnO Nanoparticales/1, 2-Napthaquinone-4-Sulphonic Acid Glassy Carbon Modified Electrode

722

Pharmaceutical Equivalence of Some Commercial Samples of Artesunate and Amodiaquine Tablets Sold in Southwestern Nigeria

723

Pharmaceutical Evaluation of Metformin HCl Products Available in the Jordanian Market

724

Pharmaceutical Evaluation of Ziziphus Jujuba Mucoadhesive Buccal Film

725

Pharmaceutical Excipient Development: The Need for Preclinical Guidance

726

Pharmaceutical Formulation of Garlic and Turmeric Dried Crude Extract and Their Synergistic Antifungal Activity and Safety

727

Pharmaceutical haute couture: educating patients about health-care choices

728

Pharmaceutical impurities: Analytical, toxicological and regulatory perspectives

729

Pharmaceutical impurities: Regulatory perspective for Abbreviated New Drug Applications

730

Pharmaceutical industry profits and cost to senior citizensʹ health

731

Pharmaceutical Industry Roundtable Abstracts

732

Pharmaceutical innovation and longevity growth in 30 developing and high-income countries, 2000–2009

733

Pharmaceutical laws and regulations in Iran: An overview

734

Pharmaceutical microcalorimetry: recent advances in the study of solid state materials

735

Pharmaceutical Nanoemulsions and Their Potential Topical and Transdermal Applications

736

Pharmaceutical Nanoparticles and the Mucin Biopolymer Barrier

737

Pharmaceutical nanotechnology for oral delivery of anticancer drugs

738

Pharmaceutical Nickel(II) Chelation Properties of 3-Hydroxyflaven, Deferiprone and Maltol Metal Chelators: A Density Functional Study

739

Pharmaceutical patent analyst – FutureScience publishing

740

Pharmaceutical patents on plant derived materials in Brazil: Policy, law and statistics

741

Pharmaceutical policies used by private health insurance companies in Saudi Arabia

742

Pharmaceutical powder technology — from art to science: the challenge of the FDAʹs Process Analytical Technology initiative

743

Pharmaceutical powders analysis using FT-Raman spectrometry: Simultaneous determination of sulfathiazole and sulfanilamide

744

Pharmaceutical powders compaction: Experimental and numerical analysis of the density distribution

745

pharmaceutical prescription (Rx): Calcium, phosphate, and secundum artem

746

Pharmaceutical profiling method for lipophilicity and integrity using liquid chromatography–mass spectrometry

747

Pharmaceutical Properties of Hibiscus sabdariffa, Toward an Ideal Treatment for Hypertension

748

Pharmaceutical reform and physician strikes in Korea: separation of drug prescribing and dispensing

749

Pharmaceutical representatives

750

Pharmaceutical representatives’ beliefs and practices about their professional practice: a study in Sudan

751

Pharmaceutical Research in Wilhelmine Germany: The Case of E. Merck

752

Pharmaceutical research: paradox, challenge or dilemma?

753

Pharmaceutical risk management in Turkey: The first national overview

754

Pharmaceutical Statistics Using SAS®: A Practical Guide by Alex Dmitrienko, Christy Chuang-Stein, Ralph DʹAgostino

755

Pharmaceutical strategic purchasing requirements in Iran: Price interventions and the related effective factors

756

Pharmaceutical Strategic Purchasing: a Key to Improve Access to Medicines

757

Pharmaceutical supply chain risks: a systematic review

758

Pharmaceutical toxicology: Designing studies to reduce animal use, while maximizing human translation

759

Pharmaceutical trace analysis in aqueous environmental matrices by liquid chromatography–ion trap tandem mass spectrometry

760

Pharmaceutical Wastewater Chemical Oxygen Demand Reduction: Electro-Fenton, UV-enhanced Electro-Fenton and Activated Sludge

761

Pharmaceutical wastewater treatment by membrane bioreactor process – a case study in southern Taiwan Original Research Article

762

Pharmaceutical workers

763

PHARMACEUTICAL, FOOD AND NON-FOOD APPLICATIONS OF MODIFIED STARCHES: A CRITICAL REVIEW

764

Pharmaceutical-enantiomers resolution using immobilized polysaccharide-based chiral stationary phases in supercritical fluid chromatography

765

Pharmaceuticals and personal care products (PPCPs) and endocrine disrupting chemicals (EDCs) in stormwater canals and Bayou St. John in New Orleans, Louisiana, USA

766

Pharmaceuticals and personal care products (PPCPs) in foods. Potential risks to human health?

767

Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada

768

Pharmaceuticals and personal care products (PPCPs) in treated wastewater discharges into Charleston Harbor, South Carolina Original Research Article

769

Pharmaceuticals and the Strategic National Stockpile Program

770

Pharmaceuticals in Australia: developments in regulation and governance

771

Pharmaceuticals in groundwaters: Analytical methods and results of a monitoring program in Baden-Württemberg, Germany

772

PHARMACEUTICALS IN IRAN: AN OVERVIEW

773

Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment

774

Pharmaceuticals in the aquatic environment––a comparison of risk assessment strategies

775

Pharmaceuticals in the river Elbe and its tributaries

776

Pharmaceuticals Safety Practices-A Comparative Pilot Study

777

Pharmaceuticals Solubility is Still Nowadays Widely Studied Everywhere

778

Pharmaceuticals, alkylphenols and pesticides in Mediterranean coastal waters: Results from a pilot survey using passive samplers

779

Pharmaceuticals, hormones and bisphenol A in untreated source and finished drinking water in Ontario, Canada — Occurrence and treatment efficiency Original Research Article

780

Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: A proposed ranking system Original Research Article

781

Pharmaceuticals: a threat to drinking water? Original Research Article

782

Pharmaceuticals—our true clinical partners?

783

Pharmaciesʹ over-the-counter drug monopoly in Denmark ended

784

Pharmacies, self-medication and pharmaceutical marketing in Bombay, India

785

Pharmacist and nurse: a team approach towards primary health care or a convenient “therapeutic alliance”? Original Research Article

786

Pharmacist Interventions in Improving Clinical Outcomes in Patients with Type 2 Diabetes Mellitus Among the Underrepresented Population: A Collaborative Ambulatory Care Pharmacy Practice (CAPP) Approach

787

PHARMACIST ROLE IN GLOBAL HEALTH: A REVIEW OF LITERATURE

788

Pharmacist, the pharmaceutical industry and pharmacy education in Saudi Arabia: A questionnaire-based study

789

Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process

790

Pharmacist-Led Medication Review: Supports for New Role of Pharmacists

791

PHARMACIST-MANAGED THERAPEUTIC DRUG MONITORING SERVICE FOR ANTIEPILEPTIC DRUGS AND IMPROVED SEIZURE CONTROL

792

Pharmacist-Physician Organic Cooperation Is an Effective Strategy to Reduce the Medication-related Problems, An Experience in CKD Patients

793

Pharmacists agree: stop the pharmacy madness

794

Pharmacists as Entrepreneurs or Employees: The Role of Locus of Control

795

Pharmacists Remuneration Models in Iran and Selected Countries: a Comparative Study

796

PHARMACISTS UNDERSTANDING AND ATTITUDES TOWARDS PHARMACEUTICAL CARE IN SAUDI ARABIA

797

Pharmacists’ and physicians’ perception and exposure to drug promotion: A Saudi study

798

Pharmacists’ Attitudes and Perceived Barriers about Community Pharmacy-Based Cardiovascular Risk Screening Services

799

PHARMACISTS’ NEGLIGENCE AND PRINCIPLES OF LIABILITY

800

Pharmacists’ Perception of the Sale of Non-Clinically Proven Health Supplements in Penang, Malaysia

801

Pharmaco1logic Evaluation of the Calcitonin Analogue SB 205614 in Models of Osteoclastic Bone Resorption In Vitro and In Vhro: Comparison With Salmon Calcitonin and Elcatonin

802

Pharmacodynamic activity of lipoprotein lipase and hepatic lipase, and pharmacokinetic parameters measured in normolipidaemic subjects receiving ciprofibrate (100 or 200 mg/day) or micronised fenofibrate (200 mg/day) therapy for 23 days

803

Pharmacodynamic and/or pharmacokinetic characteristics of interactions between loreclezole and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: An isobolographic analysis

804

Pharmacodynamic Effect of N-Acetylcysteine as Adjunctive Therapy in Mild Systemic Lupus Erythematosus Patients

805

Pharmacodynamic effects of milrinone with and without a bolus loading infusion

806

Pharmacodynamic Effects of Prasugrel Dosing Regimens in Patients on Maintenance Prasugrel Therapy: Results of a Prospective Randomized Study

807

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Patients With Stable Coronary Artery Disease: Results of the SWAP-2 Study (Switching Anti Platelet-2)

808

PHARMACODYNAMIC INTERACTION OF GARLIC WITH PROPRANOLOL IN ISCHEMIA-REPERFUSION INDUCED MYOCARDIAL DAMAGE

809

Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects Original Research Article

810

Pharmacodynamic interactions of amodiaquine and its major metabolite desethylamodiaquine with artemisinin, quinine and atovaquone in Plasmodium falciparum in vitro

811

Pharmacodynamic profile of short-term readministration of abciximab in healthy subjects

812

Pharmacodynamic profile of the direct thrombin antagonist bivalirudin given in combination with the glycoprotein IIb/IIIa antagonist eptifibatide

813

Pharmacodynamic profiling of levofloxacin and gatifloxacin using Monte Carlo simulation for community-acquired isolates of Streptococcus pneumoniae

814

Pharmacodynamic study on acute hypotensive activities of Carissa carandas extract in normal rats

815

Pharmacodynamic–pharmacokinetic profiles of metformin hydrochloride from a mucoadhesive formulation of a polysaccharide with antidiabetic property in streptozotocin-induced diabetic rat models

816

Pharmacodynamics and microbiology of trovafloxacin in animal models of surgical infection

817

Pharmacodynamics and pharmacokinetics of cefoperazone and cefamandole in dogs following single dose intravenous and intramuscular administration

818

Pharmacodynamics and pharmacokinetics of flumequine in pigs after single intravenous and intramuscular administration

819

Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: Comparison with single and multiple daily doses of ilgrastim

820

Pharmacodynamics in the elderly

821

Pharmacodynamics of alpha2-adrenoceptor agonists

822

Pharmacodynamics of antimicrobial therapy in surgery

823

Pharmacodynamics of immunosuppressive drugs

824

Pharmacodynamics of Intermittent- and Continuous-Infusion Gefepime Alone and in Combination with Once-Daily Tobramycin against Pseudomonas aeruginosa in an in vitro Infection Model

825

Pharmacodynamics of mivacurium in severely burned patients

826

Pharmacodynamics of warfarin in cats

827

Pharmacodynamics Studies on Ricobendazole In Male Rats

828

Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia

829

Pharmacodynamics: Relation to Antimicrobial Resistance

830

Pharmacodynamics: Relation to antimicrobial resistance

831

Pharmacoeconomic Aspects of Treating Hemorrhoidal Disease-Cost of Illness Study Based on Data from Balkan Country with Recent History of Social and Economic Transition

832

Pharmacoeconomic assessment of midazolam in two emergency departments

833

Pharmacoeconomic Education for Pharmacy Students in Bosnia and Herzegovina

834

Pharmacoeconomic Evaluation of Anti-Diabetic Therapy in A Nigerian Tertiary Health Institution

835

Pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes

836

Pharmacoeconomic Impact Evaluation of Statin Adherence in High-risk Unselected Post Myocardial Infarction Population: an Administrative Database-guided Analysis

837

Pharmaco-economic issues for diabetes therapy

838

Pharmacoeconomic issues in antihypertensive therapy

839

Pharmacoeconomic study of antibiotics used in the treatment of lower respiratory tract infections in ICU patients: A case study in an Egyptian hospital

840

Pharmacoeconomics Analysis in a Pediatric Population

841

Pharmaco-economics analysis, as a strategy on facilitating choices between health and non-health programs in the establishment of the national health care system

842

Pharmacoeconomics and health outcomes: state of the art

843

Pharmacoeconomics and Utilization of Intravenous Iron Sucrose in a Tertiary Care Hospital

844

Pharmacoeconomics and Utilization of Intravenous Proton Pump Inhibitors in a Tertiary Care Hospital

845

Pharmacoeconomics for surgeons

846

Pharmacoeconomics in Iran: It Is Time to Take It into Practice

847

Pharmacoeconomics of Angiotensin Converting Enzyme Inhibitors in Heart Failure

848

PHARMACO-ECONOMICS OF MICRODOSING CLINICAL TRIALS IN DRUG DEVELOPMENT PROCESS

849

Pharmacoeconomics of pneumonia

850

Pharmacoeconomics: what is it and where is it going?

851

Pharmacoeconomics; an Appropriate Tool for Policy Makers or Just a New Field of Research in Iran?

852

Pharmaco-EEG-based assessment of interaction between ethanol and levetiracetam

853

Pharmacoepidemiological study of self-medication in adults attending pharmacies in Alexandria, Egypt

854

Pharmacoepidemiology of Drugs Used in Indoor Patients of Orthopaedic Department at a Tertiary Care Hospital

855

Pharmacoepidemiology Safety Study of Fibrate and Statin Concomitant Therapy

856

Pharmacogenetic Effect of Thiopurine Methyl Transferase (TPMT) Gene Expression and Serum TNF on the Imuran Response in Ulcerative Colitis (UC) Iraqi Patients

857

Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure Original Research Article

858

Pharmacogenetic prediction of clozapine response Original Research Article

859

Pharmacogenetic Studies of Depression

860

Pharmacogenetic Testing for Warfarin Dosing Still Awaits Validation

861

Pharmacogenetic variation of SLC47A1 gene and metformin response in type2 diabetes patients

862

Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450–metabolized drugs

863

Pharmacogenetics and adverse drug reactions

864

Pharmacogenetics and antipsychotic drugs

865

Pharmacogenetics and drug-induced nephrotoxicity in renal transplant recipients

866

Pharmacogenetics and future drug development and delivery

867

Pharmacogenetics and Personalized Medicine in Pancreatic Cancer

868

Pharmacogenetics draws an ACE

869

Pharmacogenetics in Cardiovascular Antithrombotic Therapy

870

Pharmacogenetics of anti-estrogen treatment of breast cancer

871

Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine

872

Pharmacogenetics of clozapine response

873

Pharmacogenetics of CYP enzymes and drug transporters: remarkable recent advances

874

Pharmacogenetics of disease-modifying anti-rheumatic drugs

875

Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management

876

Pharmacogenetics of inflammatory bowel disease

877

Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother

878

Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy

879

Pharmacogenetics, the Promise of Translating Personalized Medicine into Clinical Pediatrics

880

Pharmacogenetics: Fitting the Drug to the Patient

881

Pharmacogenetics: Is the right drug for the right patient sufficient?

882

Pharmacogenetics: Yeast Lead the Way

883

Pharmacogenetics-Oriented Therapeutic Drug Monitoring of Digoxin in Critically ILL Patients

884

Pharmacogenetics-Oriented Therapeutic Drug Monitoring of Digoxin in Critically ILL Patients

885

Pharmacogenomic approaches in the treatment of breast cancer by tamoxifen

886

Pharmacogenomic determination of genes associated with sensitivity or resistance of tumor cells to curcumin and curcumin derivatives

887

Pharmacogenomic profiling of an oxidative stress-mediated spongiform encephalopathy

888

Pharmacogenomic Profiling of the PI3K/PTEN Pathway in Sporadic Breast Cancer

889

Pharmacogenomics and -genetics in colorectal cancer

890

Pharmacogenomics and the Failing Heart: Are We Waiting for Godot?

891

Pharmacogenomics for Infectious Diseases

892

pharmacogenomics implementation and hurdles to overcome; in the context of a developing country

893

Pharmacogenomics in bladder cancer

894

Pharmacogenomics in bladder cancer

895

Pharmacogenomics in Cancer Chemotherapy

896

Pharmacogenomics in cancer drug discovery and development: inhibitors of the Hsp90 molecular chaperone

897

Pharmacogenomics in non-small-cell lung cancer chemotherapy

898

Pharmacogenomics of organic anion-transporting polypeptides (OATP)

899

Pharmacogenomics- The Promise of Personalized Medicine

900

Pharmacogenomics: New paradigms for targeted therapy based on individual response to drugs

901

Pharmacogenomics: New paradigms for targeted therapy based on individual response to drugs

902

Pharmacogenomics: out of the lab and into the community

903

Pharmacognostic and Acute Toxicity Study of Burkea Africana Root

904

Pharmacognostic and AntiInflammatory Properties of Securigera securidaca Seeds and Seed Oil

905

Pharmacognostic and Elemental Analysis of the Leaves of Tapinanthus globifer (A. Rich). Tiegh

906

Pharmacognostic and Physico-chemical Investigation of Barleria cristata Linn. (Leaf) for Quality Control Assessment

907

Pharmacognostic and phytochemical investigation of Heracleum persicum Desf. ex Fischer

908

Pharmacognostic and Preliminary Phytochemical Investigation on Doronicum scorpioides Roots

909

Pharmacognostic Characteristics and Mutagenic Studies of Alstonia boonei De Wild

910

Pharmacognostic Characteristics of Hibiscus sabdariffa L. as a Means of Monitoring Quality

911

Pharmacognostic evaluation and physico-chemical analysis of Lantana camara (Linn.) flowers

912

Pharmacognostic evaluation of Achyranthes coynei: Leaf

913

Pharmacognostic Evaluation of Maesobotrya barteri (Baill) Hutch and Maesobotrya dusenii Pax (Euphorbiaceae) Leaves

914

Pharmacognostic Evaluation of Oxalis pes-caprae L. (Family Oxalidaceae)

915

Pharmacognostic evaluation of the leaves of Mitracarpus scaber Zucc (Rubiaceae)

916

Pharmacognostic Evaluation of the Leaves of Secamone afzelii (Schult) K Schum (Asclepiadaceae)

917

Pharmacognostic Investigation of the Leaves and Stems of Viburnum erubescens Wall.ex DC

918

Pharmacognostic Profile and Screening of Anti-Proliferative Potential of Methanolic Extract of Tripterygium wilfordii Plant on WRL-68 Cell Line and Function of Polycystin‐1

919

Pharmacognostic Standardization and Chromatographic Fingerprint Analysis on Triterpenoidal Constituents of the Medicinally Important Plant Artocarpus heterophyllus by High‑Performance Thin Layer Chromatography Technique

920

Pharmacognostic study of Argyreia pilosa stem

921

Pharmacognostic, Physicochemical and Phytochemical Investigations on Aerial Parts of Argemone mexicana L.

922

Pharmacognostical and physico-chemical evaluations of Cardiospermum halicacabum L. seeds

923

Pharmacognostical Sources of Popular Medicine To Treat Alzheimer’s Disease

924

Pharmacognostical study of Chorisia insignis HBK. grown in Egypt

925

Pharmacognostical, physico-chemical and contamination studies of polyherbal formulation “qurse pudina”

926

Pharmacokinetic analysis by high-performance liquid chromatography of intravenous nordihydroguaiaretic acid in the mouse

927

Pharmacokinetic analysis in serum of genistein administered subcutaneously to neonatal mice

928

Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography

929

Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging

930

Pharmacokinetic analysis of nicotine when using non-combustion inhaler type of tobacco product in Japanese adult male smokers

931

Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates

932

Pharmacokinetic and drug interaction studies of Pefloxacin with paracetamol (NNAID) in healthy volunteers in Pakistan

933

Pharmacokinetic and excretion study of three secoiridoid glycosides and three flavonoid glycosides in rat by LC–MS/MS after oral administration of the Swertia pseudochinensis extract

934

Pharmacokinetic and fetal cardiovascular effects of enalaprilat administration to maternal rhesus macaques, ,

935

Pharmacokinetic and Hemodynamic Responses to Oral Sildenafil During Invasive Testing in Children With Pulmonary Hypertension

936

Pharmacokinetic and milk penetration of a difloxacin long-acting poloxamer gel formulation with carboxy-methylcellulose in lactating goats

937

Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part 1. Absolute bioavailability of 0.25 mg of ganirelix after a single subcutaneous injection in healthy female volunteers

938

Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Doseproportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers

939

Pharmacokinetic and Pharmacodynamic Comparison of Controlled-Release Carvedilol and Immediate-Release Carvedilol at Steady State in Patients with Hypertension

940

Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida

941

Pharmacokinetic and pharmacodynamic modelling of marbofloxacin administered alone and in combination with tolfenamic acid in goats

942

Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation

943

Pharmacokinetic and pharmacodynamic properties of the new AEDs: A review article.

944

Pharmacokinetic and tissue distribution of doxycycline in broiler chickens pretreated with either: Diclazuril or halofuginone

945

Pharmacokinetic and toxicological data of spirolides after oral and intraperitoneal administration

946

Pharmacokinetic and tumour-photosensitizing properties of methoxyphenyl porphyrin derivative

947

Pharmacokinetic applicability of a validated liquid chromatography tandem mass spectroscopy method for orally administered curcumin loaded solid lipid nanoparticles to rats

948

Pharmacokinetic application of fuzzy structure identification and reasoning

949

Pharmacokinetic behavior and pharmacokinetic/pharmacodynamic integration of marbofloxacin after subcutaneous administration in goats

950

Pharmacokinetic behavior of marbofloxacin after intravenous, subcutaneous and intramuscular administrations in llamas (Lama glama)

951

Pharmacokinetic Behavior of Phenytoin in Head Trauma and Cerebrovascular Accident Patients in an Iranian Population

952

Pharmacokinetic Behavior of Theophylline following PEEP in Critically Ill Patients with Acute Lung Injury

953

Pharmacokinetic behaviour of ACP gel, an autocrosslinked hyaluronan derivative, after intraperitoneal administration

954

Pharmacokinetic behaviour of enrofloxacin in greater rheas following a single-dose intramuscular administration

955

Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs

956

Pharmacokinetic comparisons of different combinations of Shaoyao-Gancao-Decoction in rats: Simultaneous determination of ten active constituents by HPLC–MS/MS

957

Pharmacokinetic comparisons of puerarin, daidzin and the glucuronide metabolite of puerarin after administration of total flavonoid from Gegen alone and total flavonoid from Gegen combined with total saponin from Sanqi in rats under different physiologica

958

Pharmacokinetic Computer Simulations of the Relationship Between In Vivo and In Vitro Neuroreceptor Subtype Selectivity of Radioligands

959

Pharmacokinetic considerations for targeted drug delivery

960

Pharmacokinetic differences between ethnic groups

961

Pharmacokinetic differences between ethnic groups

962

Pharmacokinetic dosing of aminoglycosides: a controlled trial

963

Pharmacokinetic Drug Food Interaction Study of Nateglinide and Pomegranate Fruit Juice

964

Pharmacokinetic drug‑drug interaction and their implication in clinical management

965

Pharmacokinetic Effect of MDR Gene Polymorphism rs2032582 on the Therapeutic Response in Iraqi Patients with Acute Myeloid Leukemia

966

Pharmacokinetic enhancement of marbofloxacin by alpha-1-monolaurin pre-treatment in broiler chickens

967

PHARMACOKINETIC EVALUATION OF CLARITHROMYCIN ORAL CONTROLLED RELEASE MATRIX TABLETS FOR DESIRED BIOAVAILABILITY AND IMPROVED PATIENT COMPLIANCE

968

Pharmacokinetic evaluation of dipfluzine and its three metabolites in rat plasma using liquid chromatography–mass spectrometry

969

Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug

970

Pharmacokinetic evaluation of tramadol and its major metabolites after single oral sustained tablet administration in the dog: a pilot study

971

Pharmacokinetic Evaluation of Two Doses of Aminophylline/Theophylline Administered as Multiple Intermittent Infusions to Iranian Apneic Premature Neonates

972

Pharmacokinetic Interaction of Salbutamol Coadministered with Vasicine Isolated from Adhathoda vasica on Rabbit

973

Pharmacokinetic Interaction Study for Simvastatin and Parsley and Its Plasma Quantification Using LC-MS: A Focus on Drug Metabolic Enzymes

974

Pharmacokinetic interactions between chloroquine, sulfadoxine and pyrimethamine and their bioequivalence in a generic fixed-dose combination in healthy volunteers in Uganda

975

Pharmacokinetic Interactions between Intravenous Ciprofloxacin and Oral Ferrous Sulfate

976

Pharmacokinetic interactions: The effects of selected herbal extracts on permeation of P-glycoprotein substrate drugs across excised pig intestinal tissue

977

Pharmacokinetic Investigation to Study the In Vivo Bioavailability of Thiolated Chitosan Based Repaglinide Buccal Tablets

978

Pharmacokinetic model for in vivo/in vitro correlation of intravitreal drug delivery

979

Pharmacokinetic model of daily selenium intake from contaminated seafood in Taiwan

980

Pharmacokinetic model of dioxin and furan levels in adipose tissue from Sawmill work involving chlorophenate fungicides

981

Pharmacokinetic of ALA and h-ALA induced porphyrins in the models Mycobacterium phlei and Mycobacterium smegmatis

982

Pharmacokinetic of sulfaclozine in broiler chickens

983

Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. implementation of P3 pyridine N-Oxides to deliver an orally bioavailable series containing P1 N-Benzylamides

984

Pharmacokinetic Parameters and OverResponsiveness of Iranian Population to Propranolol

985

Pharmacokinetic Parameters and Over-Responsiveness of Iranian Population to Propranolol

986

Pharmacokinetic parameters as a potential predictor of response to pharmacotherapy in benign prostatic hyperplasia: a preclinical trial using dynamic contrast-enhanced MRI

987

Pharmacokinetic parameters of valproic acid and carbamazepine from routinely collected data: Influence of patient characteristics

988

Pharmacokinetic profile of a sustained-delivery system for physostigmine in rats

989

Pharmacokinetic Profile of Controlled-Release Carvedilol in Patients with Left Ventricular Dysfunction Associated with Chronic Heart Failure or After Myocardial Infarction

990

Pharmacokinetic Profile of Plasma Levobupivacaine Following Fascia Iliaca Compartment Block for Proximal Femoral Fracture in Older Patient

991

Pharmacokinetic profile of recombination human insulin-like growth factor binding protein-1 in athymic mice

992

Pharmacokinetic Properties of a New Controlled-Release Formulation of Carvedilol

993

Pharmacokinetic studies and human absorbed dose estimation of 68Ga-(4 {[(bis (phosphonomethyl)) carbamoyl] methyl}-7,10-bis(carboxymethy l) -1,4,7,10-tetraazacyclododec-1-yl) acetic acid

994

Pharmacokinetic studies in cancer chemotherapy: Usefulness in clinical practice

995

Pharmacokinetic Studies of Enrofloxacin in Yak after Intramuscular Administration

996

Pharmacokinetic studies of metformin and glibenclamide in normal human volunteers

997

Pharmacokinetic studies of protein drugs: Past, present and future

998

Pharmacokinetic Studies of Rifampicin in Healthy Volunteers and Tuberculosis Patients

999

Pharmacokinetic studies on 5-aminolevulinic acid-induced protoporphyrin IX accumulation in tumours and normal tissues

1000

Pharmacokinetic Studies on Metoprolol - Eudragit Matrix Tablets and Bioequivalence Consideration with Mepressor®